Host of the Asymmetric Investing podcast and author of the Asymmetric Investing newsletter, focusing on long-term compounding growth stocks with asymmetric upside.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
As the dominant telehealth demand aggregator with 50% market share, Hims & Hers gains supplier pricing power; GLP-1s at $300/month plus labs and peptides create a multi-year runway to scale from $7.5B to $100B+ market cap.
Alphabet's $200B AI investment, $56B non-operating income from SpaceX/Anthropic stakes, Google Cloud growth, and Waymo optionality make it a dominant 20-year compounder at a reasonable valuation.
Branchless architecture enables 35% member CAGR and 81% financial services revenue CAGR; at 2.1x P/B (vs 4x recent high) and $18/share, SoFi's expanding product attach rate justifies a long-term hold with multiple expansion potential.